Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma
from Latest Interviews - Finance News Network Hosted by Finance News Network
17 Sept 2026 - CEO Marc Voigt outlines Immutep’s focused clinical strategy, ongoing TACTI-004 analysis and plans to return efti to the clinic in 2027.
Embed this episode
No transcript yet.
Frequently asked questions
When was this Latest Interviews - Finance News Network episode published?
This episode was published on September 16, 2026.
Can I download this Latest Interviews - Finance News Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.